President Trump Signs Drug Pricing Executive Orders: How Will They Impact Pharma and Providers?
Prescription drug pricing is emerging as one of several healthcare issues that may become a focus of the presidential race as well as contested congressional races this fall. With pending legislative attempts to control drug prices and reform the Medicare Part D prescription drug benefit stalled because of partisan disputes, President Donald Trump stepped into the fray on July 24 with a White House event unveiling four executive orders on drug pricing.
